Countries Europe
CSL Vifor and Travere Therapeutics Secure Swissmedic Approval for FILSPARI in Treatment of IgA Nephropathy
CSL Vifor and Travere Therapeutics, announced that Swissmedic has granted temporary marketing authorization for FILSPARI for the treatment of adults w...
October 18, 2024 | News
Isolere Bio by Donaldson Introduces Research-Grade IsoTag™ AAV Reagent for Superior Viral Vector Purification
Isolere Bio by Donaldson, an innovative bioprocessing technology provider, proudly announces the availability of research-grade IsoTag™ AAV reagent, ...
October 18, 2024 | News
BD and Hamilton Collaborate to Streamline Genomic Sequencing with Automation-Ready Reagent Kits
Automation-Ready Reagents Used with the Hamilton Robotics Liquid-Handler Streamlines and Helps Accelerate Lab Work Leading to Genomic Sequencing &nb...
October 15, 2024 | News
Thermo Fisher Introduces Iliad (S)TEM: Advancing Atomic-Level Insights with EELS and NanoPulser Technology
Thermo Scientific Iliad integrates electron energy loss spectroscopy (EELS) and NanoPulser electrostatic beam blanker to improve insights at the atomic lev...
October 15, 2024 | News
Leading Drug Discovery CRO NovAliX Partners with Bruker to Transform Therapeutic Innovation
Bruker Acquires Minority Stake in NovAliX in Strategic Move Partnership Leverages Synergies Between Premium Drug Discovery CRO and High-Value Life Scien...
October 11, 2024 | News
Astellas Secures Exclusive Option for AVB-101 Gene Therapy in $2.18 Billion Deal with AviadoBio
Astellas receives an exclusive option to license AVB-101, an investigational, AAV-based gene therapy in Phase 1/2 development Av...
October 11, 2024 | News
Daewoong Pharmaceutical Showcases Cutting-Edge Microneedle Drug Delivery Technology at CPHI Worldwide 2024
Daewoong Pharmaceutical (Co-CEOs Seongsoo Park and Chang-jae Lee) announced on the 9th that they will present their cutting-edge drug delivery te...
October 10, 2024 | News
Pierre Fabre and Scorpion Therapeutics Dose First Patient in Phase I/II Trial of PFL-241/STX-241, a Promising 4th Generation EGFR Inhibitor
PFL-241/STX-241 is a highly selective, and potentially best-in-class fourth generation epidermal growth factor receptor ("EGFR") inhibitor One of two EGFR...
October 09, 2024 | News
Werfen Becomes First European Partner in Seegene's Technology-Sharing Initiative, Co-Establishing NewCo in Spain
Werfen, a worldwide leader in specialized diagnostics, becomes the first European company to finalize the partnership agreement to join Seegene's technol...
October 09, 2024 | News
Synexa Life Sciences Acquires Alderley Analytical Ltd, Strengthening Bioanalytical Capabilities and Expanding European Reach
Synexa Life Sciences, a specialist biomarker and bioanalysis service provider, announces the acquisition of Alderley Analytical Ltd, based near ...
October 08, 2024 | News
Thermo Fisher Scientific Launches Accelerator™ Drug Development: Transforming Drug Development with Comprehensive CDMO and CRO Services
Company Launches Accelerator™ Drug Development, 360° Contract Development and Manufacturing Organization (CDMO) and Contract Research Organizatio...
October 07, 2024 | News
RadSep Unveils Cutting-Edge Separation Technology for Radiopharmaceuticals at EANM 2024
Best-in-class, highly selective separations technology for the radiopharmaceuticals industry Exhibitor at the European Association of Nuclear Medicine (...
October 04, 2024 | News
Evonik Launches Global Competence Network to Advance Cell Culture-Based Therapies
First point of contact for partners seeking to manufacture cell culture-based therapies more efficiently Draws on multidisciplinary team of experts Dri...
October 03, 2024 | News
SK Bioscience Acquires IDT Biologika to Accelerate Global Growth and Dominate the CDMO Industry
- SK bioscience completed the acquisition of German CDMO company IDT Biologika with over a century of history that enables immediate expansion in r...
October 02, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
